Clinical Trial Update: An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

View source ↗

Summary

This is an observational study to evaluate the safety and effectiveness of rivaroxaban in children with congenital heart disease who have had the Fontan procedu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Prevention of Venous Thromboembolism, Congenital Heart Disease | Status: ACTIVE_NOT_RECRUITING